Many illnesses are now treatable as a result of innovative medications. However, taking several substances at once can pose a risk, especially for chronically ill patients. This was recently revealed in the findings of a study by the Scientific Institute of the German health insurance company AOK. In the worst-case scenario, interaction between medications could even put the patient in hospital.
In order to actively reduce any drug interactions, Arvato Healthcare is offering care solutions that provide short and long-term benefits for both patients and insurance companies.
This and other topics, such as sustainable transport solutions, are covered in the current Newsletter “healthcare news” of the Arvato unit Arvato Healthcare.